https://jk-clinic.jp/%E7%B1%B3%E3%82%BF%E3%82%A4%E3%83%A0%E8%AA%8C%E3%81%AE%E9%81%B8%E3%81%B6%E4%BA%BA%E5%B7%A5%E7%9F%A5%E8%83%BD100%E4%BA%BA2024%E5%B9%B4%E3%80%80%E3%83%80%E3%83%95%E3%83%8D%E3%80%80%E3%82%B3%E3%83%A9/
米タイム誌の選ぶ人工知能100人2024年 ダフネ コラー Daphne Koller AI科学者 INSITRO インシトロ CEO – 川田じゅんこクリニック
川田じゅんこクリニック 内科・リウマチ科・循環器内科・呼吸器内科。リウマチ性疾患・難病の診療をしています。 下関市川中豊町7-14-7. TEL 083-254-3520
daphne kollerinsitroceo
https://allsci.com/news/bms-picks-two-ai-discovered-als-targets-from-insitro-collaboration/
BMS picks two AI-discovered ALS targets from insitro collaboration - AllSci
Mar 24, 2026 - insitro and Bristol Myers Squibb expanded their option-based discovery collaboration in amyotrophic lateral sclerosis (ALS), with Bristol Myers Squibb (BMS)...
bmspickstwodiscoveredals
https://dikajob.com.br/profiles/blogs/lilly-e-insitro-se-unem-para-desenvolver-medicamentos-metabolic-1?context=tag-insitro
Lilly e insitro se unem para desenvolver medicamentos metabólicos de siRNA alimentados por IA -...
Aug 14, 2025 - O acordo da Eli Lilly e da insitro se concentra no avanço de novos medicamentos potenciais para doenças metabólicas com base em alvos identificados por IA/ML.…
lillyinsitrounemparadesenvolver
https://www.businesswire.com/news/home/20260908648145/en/insitro-Appoints-Hideo-Makimura-as-Chief-Medical-Officer-to-Lead-Its-Transition-to-a-Clinical-Stage-Company
insitro Appoints Hideo Makimura as Chief Medical Officer to Lead Its Transition to a Clinical-Stage...
insitro, the AI therapeutics company built on causal biology, today announced the appointment of Hideo Makimura as Chief Medical Officer, effective Sept. 14....
chief medical officerinsitroappointshideomakimura
https://www.venturecapitaljournal.com/insitro-nabs-series-c/
Insitro nabs $400m in Series C financing led by CPPIB
May 24, 2022 - Insitro, a machine learning-driven drug discovery and development company, has raised $400 million in Series C financing.
series c financinginsitronabsledcppib